You are here

Article info

Article menu
Download PDFPDF
Education
Opinion
Rifaximin treatment for encephalopathy reduces hospital resource use: real-world data don’t fail to IMPRESS

Authors

  • John D Ryan Sheila Sherlock Liver Unit and UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, Pond Street, NW3 2QG, London, UK PubMed articlesGoogle scholar articles
  • Emmanuel A Tsochatzis Sheila Sherlock Liver Unit and UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, Pond Street, NW3 2QG, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Emmanuel A Tsochatzis, Sheila Sherlock Liver Unit and UCL Institute of Liver and Digestive Health, Royal Free Hospital and UCL, Pond Street, NW3 2QG, London, UK; e.tsochatzis{at}ucl.ac.uk
View Full Text

Citation

Ryan JD, Tsochatzis EA
Rifaximin treatment for encephalopathy reduces hospital resource use: real-world data don’t fail to IMPRESS
Frontline Gastroenterology 2017;8:230-231.

Publication history

  • Received May 3, 2017
  • Accepted May 6, 2017
  • First published June 29, 2017.
Online issue publication 
September 11, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.